参考文献/References:
[1] 中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志，2018，46（9）：680-694. Section of Interventional Cardiology of ChineseSociety of Cardiology, Section of Atherosclerosisand Coronary Artery Disease of Chinese Societyof Cardiology, Specialty Committee on Preventionand Treatment of Thrombosis of Chinese College ofCardiovascular Physicians. Guideline on the diagnosisand treatment of stable coronary artery disease [J] .Chinese Journal of Cardiology, 2018,46 (9): 680-694.
[2] 中国心血管病报告编写组．《中国心血管病报告2016》概要[J]．中国循环杂志，2017，32（6）：521-530． China Cardiovascular Disease Report CompilationGroup. Summary of China cardiovascular diseasereport 2016 [J]. Chinese Journal of Circulation, 2017,32 (6): 521-330.
[3] BABASHAMSI M M, HALALKHOR S, MORADIFIROUZJAH H, et al. Association of ATP-Bindingcassette transporter A1 (ABCA1)-565 C/T genepolymorphism with hypoalphalipoproteinemia andserum lipids, IL-6 and CRP levels[J]. Avicenna Journalof Medical Biotechnology, 2017, 9(1): 38-43.
[4] MOKUNO J, HISHIDA A, MORITA E, et al. ATPbindingcassette transporter A1 (ABCA1) R219K(G1051A, rs2230806) polymorphism and serumhigh-density lipoprotein cholesterol levels in a largeJapanese population: cross-sectional data from theDaiko Study[J]. Endocrine Journal, 2015, 62(6): 543-549.
[5] 袁托亚, 张迎军, 王悦喜, 等.ABCA1 基因-565C/T基因变异与冠状动脉狭窄程度的关系[J]. 中西医结合心脑血管病杂志,2019,17(15):2245-2248. YUAN Tuoya, ZHANG Yingjun, WANG Yuexi, etal. The relationship between ABCA1-565C/T genevariation and degree of coronary artery stenosis [J].Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease, 2019, 17 (15): 2245- 2248.
[6] YE Xiaodong, HE Yi, WANG Sheng, et al. Heart-typefatty acid binding protein (H-FABP) as a biomarker foracute myocardial injury and long-term post-ischemicprognosis[J]. Acta Pharmacologica Sinica, 2018, 39(7):1155-1163.
[7] 蔡玲，范雪梅，孙健，等．血清H-FABP 和cTnT水平联合测定在急性心肌梗死诊断中的作用[J]．临床心血管病杂志，2017，33（7）：643-645． CAI Ling, FAN Xuemei, SUN Jian, et al. The role ofcombined detection of serum H-FABP and cTnT levelsin the diagnosis of acute myocardial infarction [J] .Journal of Clinical Cardiology, 2017,33 (7): 643-645.
[8] 高润霖．进一步改善稳定性冠心病的诊治: 浅谈“中国稳定性冠心病诊断与治疗指南”亮点[J]. 中华心血管病杂志，2018，46（11）：833-836． GAO Ruilin. To further improve the diagnosis andtreatment of stable coronary heart disease: Talking aboutthe highlights of the "guidelines for the diagnosis andtreatment of stable coronary heart disease in China" [J].Chinese Journal of Cardiology, 2018, 46 (11): 833-836.
[9] 沈云峰，胡远贵，张洪波，等．冠状动脉病变程度与血清胱抑素、一氧化氮及超氧化物歧化酶水平的相关性研究[J]．现代检验医学杂志，2015,30（1）：82-84, 87． SHEN Yunfeng, HU Yuangui, ZHANG Hongbo, et al.Study on the relationship between severity of coronaryartery lesion and the level cystatin C ，nitric oxideand superoxide dismutase of serum [J]. Journal ofModern Laboratory Medicine, 2015,30 (1): 82-84, 87.
[10] 李华，支莹，卢彦昭，等．胱抑素C 与冠状动脉斑块性质、病变特点的相关性[J]．中华医学杂志，2015，95（1）：48-51． LI Hua, ZHI Ying, LU Yanzhao, et al. Correlationbetween cystatin C and properties and features ofcoronary plague [J]. National Medical Journal of China,2015, 95 (1): 48-51.[11 喻红波，刘阳，罗俊卿，等．血清心型脂肪酸结合蛋白对非 ST 段抬高急性冠脉综合征的诊断意义[J].武警医学，2015，26（2）：133-135． YU Hongbo, LIU Yang, LUO Junqing, et al. Diagnosticvalue of heart-type fatty-acid binding protein in serumfor non-ST-elevation acute coronary syndromes [J].Medical Journal of the Chinese People’s Armed PoliceForces, 2015, 26 (2): 133-135.
[12] 周梦迪，陈垦，李勇，等．血清FABP3 水平与冠状动脉病变及阿司匹林抵抗的关系[J]．临床心血管病杂志，2019，35（4）：348-352． ZHOU Mengdi, CHEN Ken, LI Yong， et al. Therelationship between serum FABP3 level and coronaryartery disease and aspirin resistance [J]. Journal ofClinical Cardiology(China), 2019,35 (4): 348-352.
[13] 付伟，黄林，刘文静，等．牦牛和雄性不育犏牛睾丸FABP5 和FABP9 基因mRNA 水平及能量代谢相关酶活力的比较[J]．畜牧兽医学报，2015，46（4）：561-567． FU Wei, HUANG Lin, LIU Wenjing ,et al. Comparisonof the mRNA levels of FABP5 and FABP9 genesand activities of some enzymes related to energymetabolism in the testes of yak and sterile F1 malehybrids between male cattle and female yak [J]. ActaVeterinaria et Zootechnica Sinica, 2015, 46 (4): 561-567.
[14] 李佳，刘晓婷，王霞，等．舒血宁治疗急性重度一氧化碳中毒的效果及对患者心型脂肪酸结合蛋白的影响[J]．广东医学，2015，36（21）：3392-3394. LI Jia, LIU Xiaoting, WANG Xia, et al. Effect of ShuXuening in treating acute severe carbon monoxidepoisoning and its effect on patients’ cardiac fatty acidbinding protein [J]. Guangdong Medical Journal, 2015,36 (21): 3392-3394.
[15] 谭玉林，唐艳艳，张敏，等．ABCA1 介导胆固醇外流及抗炎的信号通路研究进展[J]．生理科学进展，2015，46（1）：52-56． TAN Yulin, TANG Yanyan, ZHANG Min, et al. Researchprogress on ABCA1-mediated cholesterol efflux andanti-inflammatory signaling pathways [J]. Progress inPhysiological Sciences, 2015, 46 (1): 52-56.
[16] 马秋洁，刘本荣，田朝伟，等．ABCG1 基因多态对转录活性及冠心病易感性的影响[J]．中华急诊医学杂志，2017，26（6）：685-692． MA Qiujie, LIU Benrong, TIAN Chaowei, et al.Effects of the polymorphisms in ABCG1 gene onthe transcription activity and the susceptibility withcoronary artery disease [J]. Chinese Journal ofEmergency Medicine, 2017, 26 (6): 685-692.
[17] LAMON-FAVA S, HERRINGTON D M, HORVATHK V, et al. Effect of hormone replacement therapy onplasma lipoprotein levels and coronary atherosclerosisprogression in postmenopausal women according totype 2 diabetes mellitus status[J]. Metabolism: Clinicaland Experimental, 2010, 59(12): 1794-1800.
[18] 杨博．ABCA1 基因rs363717 与冠心病易感性的关联研究[J]．天津中医药大学学报，2019，38（4）：364-368． YANG Bo. The studies of the association betweenABCA1 gene rs363717 with blood lipids and coronaryheart disease susceptibility[J]. Journal of TianjinUniversity of Traditional Chinese Medicine, 2019, 38(4): 364-368.
相似文献/References:
[1]韩瑞玲,李 艳,吴 薇.武汉地区冠心病患者氯吡格雷药物代谢相关基因CYP2C19的多态性分布分析[J].现代检验医学杂志,2015,30(03):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
HAN Rui-ling,LI Yan,WU Wei.Analysis of the Polymorphism Distribution of Clopidogrel Metabolism
Related Gene CYP2C19 in Patients with Coronary Artery Disease in Wuhan[J].Journal of Modern Laboratory Medicine,2015,30(02):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
[2]洪骏,王锋,印中鹏,等.冠心病患者血浆纤维蛋白原与脂蛋白相关磷脂酶A2水平[J].现代检验医学杂志,2015,30(05):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
HONG Jun,WANG Feng,YIN Zhong-peng,et al.Levels of Plasma Lipoprotein Associated Phospholipase A2
and Fibrinogen in Patients with Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2015,30(02):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
[3]赵佳a,姚创利a,左林,等.冠心病患者血清同型半胱氨酸对血脂和锰超氧化物歧化酶的影响[J].现代检验医学杂志,2015,30(05):44.[doi:10.3969/j.issn.1671-7414.2015.05.013]
ZHAO Jiaa,YAO Chuang-lia,ZUO Lin,et al.Effects of Homocysteine on Blood Lipid and Manganese Superoxide
Dismutase in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2015,30(02):44.[doi:10.3969/j.issn.1671-7414.2015.05.013]
[4]李 垚,杨 平.早发冠心病触珠蛋白水平及其在免疫调节中的作用研究[J].现代检验医学杂志,2015,30(01):98.[doi:10.3969/j.issn.1671-7414.2015.01.027]
LI Yao,YANG Ping.Role of Haptoglobin in the Immunomodulatory
in Patients with Premature Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2015,30(02):98.[doi:10.3969/j.issn.1671-7414.2015.01.027]
[5]张 蕾,陈 捷,陈玉婷.冠心病并发恶性肿瘤患者Ghrelin/obestatin比值变化及意义[J].现代检验医学杂志,2016,31(04):104.[doi:10.3969/j.issn.16717-414.2016.04.029]
ZHANG Lei,CHEN Jie,CHEN Yu-ting.Change and Significance of Ghrelin/Obestatin in Patients
with Coronary Heart Disease Complicated with Malignant Tumor[J].Journal of Modern Laboratory Medicine,2016,31(02):104.[doi:10.3969/j.issn.16717-414.2016.04.029]
[6]赵 佳,左 林,姚创利,等.冠心病患者血清同型半胱氨酸水平与氧化应激的关系研究[J].现代检验医学杂志,2016,31(05):27.[doi:10.3969/j.issn.1671-7414.2016.05.007]
ZHAO Jia,ZUO Lin,YAO Chuang-li,et al.Study on the Relationship between Serum Homocysteine Levels
and Oxidative Stress in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2016,31(02):27.[doi:10.3969/j.issn.1671-7414.2016.05.007]
[7]姚创利,黎 阳,鲁旭娟,等.超氧化物歧化酶及其同工酶和超敏C-反应蛋白与冠心病的关系[J].现代检验医学杂志,2016,31(05):73.[doi:10.3969/j.issn.1671-7414.2016.05.019]
YAO Chuang-li,LI Yang,LU Xu-juan,et al.Relationship of Superoxide Dismutase Isoenzyme and High
Sensitive C-Reactive Protein with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2016,31(02):73.[doi:10.3969/j.issn.1671-7414.2016.05.019]
[8]黄生金,郑利平,陆俊佳,等.广西地区壮族和汉族冠心病患者胱抑素C水平及其基因多态性的比较研究[J].现代检验医学杂志,2017,32(03):26.[doi:10.3969/j.issn.1671-7414.2017.03.007]
HUANG Sheng-jin,ZHENG Li-ping,LU Jun-jia,et al.Comparative Study of Cystatin C and Its Gene Polymorphism of Pati
ents
with Coronary Heart Disease between Zhuang and Han in Guangxi Region[J].Journal of Modern Laboratory Medicine,2017,32(02):26.[doi:10.3969/j.issn.1671-7414.2017.03.007]
[9]王跃帮,吴 娟,崔 倩,等.IL-6基因启动子区域-572C>G和-174G>C多态性与江苏宿迁汉族人群冠心病的相关性[J].现代检验医学杂志,2018,33(03):31.[doi:10.3969/j.issn.1671-7414.2018.03.010]
WANG Yue-bang,WU Juan,CUI Qian,et al.Association between Interleukin-6-572C>G
and -174G>C Gene Polymorphism in the Promoter Region
and Coronary Heart Disease of Han Population in Suqian of Jiangsu[J].Journal of Modern Laboratory Medicine,2018,33(02):31.[doi:10.3969/j.issn.1671-7414.2018.03.010]
[10]刘亚东,冯莉莉,王海晶,等.冠心病患者血清Lp-PLA2与HCY检测及其与冠状动脉病变程度的相关性分析[J].现代检验医学杂志,2018,33(06):83.[doi:10.3969/j.issn.1671-7414.2018.06.022]
LIU Ya-dong,FENG Li-li,WANG Hai-jing,et al.Detection of Serum Lp-PLA2 and HCY in Patients with Coronary Heart Disease and Its Correlation with the Degree of Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2018,33(02):83.[doi:10.3969/j.issn.1671-7414.2018.06.022]